Alex A. Adjei
- Oncology top 0.05%
- Lung Cancer Research Studies 80
- Colorectal Cancer Treatments and Studies 59
- Cancer Treatment and Pharmacology 55
- Cancer-related Molecular Pathways 42
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 40
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 159
- Molecular Biology top 0.2%
- PI3K/AKT/mTOR signaling in cancer 54
- Cancer therapeutics and mechanisms 52
- Pathology and Forensic Medicine top 0.2%
- Co-authors
- Julian R. MolinaSteven E. SchildPing YangStephen D. CassiviGrace K. DyIrene M. GhobrialT. E. WitzigYujie Zhao
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (124 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Alex A. Adjei
461 papers receiving 25.6k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Oncology 11.5k
- Cancer Research 4.4k
- Pulmonary and Respiratory Medicine 8.2k
- Molecular Biology 12.9k
- Pathology and Forensic Medicine 2.5k
Countries citing papers authored by Alex A. Adjei
This map shows the geographic impact of Alex A. Adjei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex A. Adjei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex A. Adjei more than expected).
Fields of papers citing papers by Alex A. Adjei
This network shows the impact of papers produced by Alex A. Adjei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex A. Adjei. The network helps show where Alex A. Adjei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alex A. Adjei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2021 | 4 | |
| 5 | 2017 | 0 | |
| 6 | 2016 | 29 | |
| 7 | 2015 | 16 | |
| 8 | 2015 | 101 | |
| 9 | Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factorbreakdown → | 2015 | 438 |
| 10 | 2013 | 46 | |
| 11 | 2012 | 42 | |
| 12 | 2011 | 22 | |
| 13 | 2011 | 74 | |
| 14 | 2008 | 41 | |
| 15 | 2007 | 30 | |
| 16 | 2006 | 109 | |
| 17 | 2005 | 100 | |
| 18 | 2005 | 155 | |
| 19 | Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines. | 2001 | 87 |
| 20 | Comparison of potential markers of farnesyltransferase inhibition. | 2000 | 103 |
About Alex A. Adjei
Alex A. Adjei is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 476 papers that have together received 26.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (159 papers), Lung Cancer Research Studies (80 papers), Colorectal Cancer Treatments and Studies (59 papers), Cancer Treatment and Pharmacology (55 papers), PI3K/AKT/mTOR signaling in cancer (54 papers), Cancer therapeutics and mechanisms (52 papers), Cancer-related Molecular Pathways (42 papers) and Cancer Genomics and Diagnostics (40 papers). The work is most often cited by research in Oncology (11.5k citations), Cancer Research (4.4k citations) and Pulmonary and Respiratory Medicine (8.2k citations). Alex A. Adjei has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Julian R. Molina, Steven E. Schild, Ping Yang, Stephen D. Cassivi, Grace K. Dy, Irene M. Ghobrial, T. E. Witzig, Yujie Zhao, Solange Peters and Ronald S. Go. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.